14–17 October 2027
IFEMA Madrid
Congress Governance
Discover the mission, history, and governing committee guiding the Global Society for Neurological Restoration and GCNR 2027.
International Medical Association
The Global Society for Neurological Restoration (GSNR) is a premier international medical association dedicated to advancing the science and clinical practice of neuroregeneration. Founded in 2009, GSNR represents a multidisciplinary membership of over 6,000 professionals committed to reversing the effects of neurodegenerative disease, stroke, and neurotrauma.
To provide a rigorous, independent, and globally accessible platform for the dissemination of transformative research in neuroimmunology and restorative neurology, ultimately improving patient outcomes worldwide.
A world where neurological damage is no longer permanent, but a treatable condition managed through targeted, restorative interventions.
From its inaugural meeting in Geneva with 400 attendees to its current status as a cornerstone event in the global medical calendar, the GCNR has consistently driven the narrative of neurological care. Past congresses have served as the launchpad for pivotal clinical trial results and international consensus guidelines.
Worldwide Reach
By bringing together over 2,000 delegates from 70+ countries, GCNR acts as a vital catalyst for cross-border research initiatives, standardising best practices, and ensuring equitable access to emerging therapeutic knowledge.
Global Imperative
As the global burden of neurological disorders continues to rise, the need for effective, restorative therapies has never been more urgent. GCNR 2027 matters because it breaks down the silos between immunology and neurology, fostering the interdisciplinary collaborations required to solve the most complex challenges in human health.
Official Address to the International Scientific Community
On behalf of the Global Society for Neurological Restoration (GSNR) and the GCNR 2027 Organising Committee, it is my distinct privilege to welcome you to the 18th Annual Global Congress on Neurological Restoration, taking place in the culturally rich and vibrant capital of Madrid, Spain, from 14–17 October 2027.
Our field is undergoing a profound paradigm shift. For decades, the central nervous system was viewed as an immunologically privileged organ, isolated from the body's protective systems. Today, we stand on a new frontier—one where we recognise that the immune system is not an enemy to be suppressed, but a key ally. Under this year's core theme, 'Synaptic Frontiers: Harnessing Immunology for Neural Repair', we will explore the intricate dialogues between neuroimmunology, synaptic plasticity, bioelectronic medicine, and stem cell biology.
GCNR 2027 serves as the premier global gathering for clinicians, neuroscientists, biomedical engineers, and rehabilitation specialists. Over four intensive days, our scientific programme will highlight breakthrough clinical trials, advanced micro-surgical techniques, novel drug delivery models, and neuroprosthetic systems that bypass spinal lesions. We are bringing together leading experts to debate and translate laboratory discoveries into life-altering clinical therapies.
Madrid, with its proud and enduring history of scientific inquiry dating back to Santiago Ramón y Cajal, offers the perfect backdrop for these discussions. We hope that you will engage fully in both the scientific program and the unique social opportunities, fostering collaborative networks that span the globe.
Thank you for your tireless dedication to scientific progress and patient care. We look forward to welcoming you in person to Madrid for what promises to be a landmark congress in neurorestoration.
With warmest regards,
Our steering committee consists of leading clinical researchers, digitalisation pioneers, and health policy advisors from across the globe. Each member coordinates a specialised track to ensure rigorous peer review and strict scientific integrity.
Steering Members:
6 International Faculty
Abstract Review Board:
45 Peer Reviewers
Endorsing Societies:
12 Global Health Bodies
Congress Faculty Profile
PhD, MSc
Professor of Neurobiology & Neuroimmunology
Harvard Medical School
United States Faculty
Academic Biography & Scope
Prof. Clara Sterling is a pioneer in microglia-mediated synaptic pruning and target-driven neuroimmunotherapy. Over the past twenty years, her research group has decoded how glial cells guide axonal pathfinding and synaptic stability. Her keynote lecture at GCNR 2027 will address therapeutic microglia modulation as a tool for synaptic rebuilding in progressive degenerative diseases.